01 1Kaletra
02 3Paxlovid
03 1Viekira
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 283
2018 Revenue in Millions : 336
Growth (%) : -16
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 36
2018 Revenue in Millions : 178
Growth (%) : -80
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 76
2020 Revenue in Millions : 0
Growth (%) : New Launch in 2021
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 18,933
2021 Revenue in Millions : 76
Growth (%) : 24,812
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 1,279
2022 Revenue in Millions : 18,933
Growth (%) : -93
LOOKING FOR A SUPPLIER?